So revenue is up 24%, however EBITDA is down
The decline in EBITDA is due to delay in shipment of devices.
This doesn't hold up to me - how can revenue be up, but EBITDA be down, unless costs are up, either in the cost of good sold or in operating expenses.
Yes if they had shipped those units in June rather than July, EBITDA would be higher (as would revenue even more-so), however revenue is already up 24% despite the delay in shipping, so somewhere costs must be up. I can't see how they can blame a decline in EBITDA on delayed sales, when revenue is already up 24%.
- Forums
- ASX - By Stock
- BCC
- Ann: Trading Update for FY2022 and FY2023
Ann: Trading Update for FY2022 and FY2023, page-6
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BCC (ASX) to my watchlist
|
|||||
Last
14.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.53M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 140000 | 14.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 19766 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 140000 | 0.140 |
1 | 22499 | 0.135 |
2 | 59099 | 0.110 |
1 | 6000 | 0.095 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 19766 | 1 |
0.165 | 10000 | 2 |
0.170 | 1003 | 1 |
0.185 | 7500 | 1 |
0.190 | 20000 | 1 |
Last trade - 07.00am 16/07/2024 (20 minute delay) ? |
Featured News
BCC (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online